✦ LIBER ✦

Efficacy of intravitreal bevacizumab (Avastin®) therapy for early and advanced neovascular age-related macular degeneration

✍ Scribed by Ilse Krebs; Shilla Lie; Ulrike Stolba; Florian Zeiler; Stefan Felke; Susanne Binder

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravitreal bevacizumab (Avastin) for o

✍ S. Aisenbrey; F. Ziemssen; M. Völker; F. Gelisken; P. Szurman; G. Jaissle; S. Gr 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 569 KB

Intravitreal bevacizumab (Avastin®) for

✍ Karen Bjerg Pedersen; Anne Katrin Sjølie; Flemming Møller 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 245 KB

Intravitreal Bevacizumab (Avastin) for N

✍ Christine Y. Chen; Tien Y. Wong; Wilson J. Heriot 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Combined intravitreal bevacizumab and ph

✍ Markus S. Ladewig; Stefanie E. Karl; Victoria Hamelmann; Hans-Martin Helb; Hendr 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 625 KB

Intravitreal bevacizumab therapy for neo

✍ Maura Lucy Abrahám-Marin; Carlos Fernando Cortés-Luna; Griselda Álvarez-Rivera; 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 208 KB

Triple therapy for neovascular age-relat

✍ Ehmann, David; García, Raúl 📂 Article 📅 2010 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 95 KB